December 26th, 2016
•Identifying novel drug targets that transition from pre-clinical testing to human trials is a scientific priority. To that end, here we describe a functional genomics approach for examining the impact of gene depletion on cancer cell line spheroids, which more appropriately model human cancers in vivo.
Related Videos
Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models Video (Video) | JoVE
Preparation and Metabolic Assay of 3-dimensional Spheroid Co-cultures of Pancreatic Cancer Cells and Fibroblasts Video (Video) | JoVE
Longitudinal Intravital Imaging of Brain Tumor Cell Behavior in Response to an Invasive Surgical Biopsy Video (Video) | JoVE
Assessing Cell Viability and Death in 3D Spheroid Cultures of Cancer Cells Video (Video) | JoVE
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions Video (Video) | JoVE
A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery Video (Video) | JoVE
Evaluating Cell Death Using Cell-Free Supernatant of Probiotics in Three-Dimensional Spheroid Cultures of Colorectal Cancer Cells Video (Video) | JoVE
A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells Video (Video) | JoVE
Circulating Tumor Cell Lines: an Innovative Tool for Fundamental and Translational Research Video (Video) | JoVE
Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype Video (Video) | JoVE
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved